NPI: 1043242563 · LOS ANGELES, CA 90034 · Health Maintenance Organization · NPI assigned 07/07/2006
Authorized official DAVIDOFF, RAMIN controls 20+ related entities in our dataset. Read more
| Authorized Official | DAVIDOFF, RAMIN (EXECUTIVE MEDICAL DIRECTOR) |
| NPI Enumeration Date | 07/07/2006 |
Other providers sharing the same authorized official: DAVIDOFF, RAMIN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 90,190 | $251K |
| 2019 | 120,811 | $594K |
| 2020 | 80,530 | $2.12M |
| 2021 | 111,654 | $4.02M |
| 2022 | 121,910 | $4.44M |
| 2023 | 158,372 | $7.48M |
| 2024 | 202,035 | $10.79M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 90,555 | 89,134 | $6.20M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 53,014 | 52,257 | $4.84M |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 22,243 | 21,756 | $1.25M |
| 91320 | 6,243 | 6,239 | $1.03M | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 74,230 | 72,231 | $1.03M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9,500 | 9,395 | $1.01M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 5,659 | 4,355 | $1.00M |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 19,725 | 14,646 | $988K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 19,370 | 19,004 | $793K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 2,555 | 1,658 | $545K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 74,032 | 73,807 | $528K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 20,411 | 11,837 | $504K |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | 465 | 454 | $465K |
| 67028 | Intravitreal injection of a pharmacologic agent | 2,190 | 2,128 | $433K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 13,747 | 10,475 | $406K |
| 90480 | 7,932 | 7,918 | $401K | |
| 90662 | 3,674 | 3,674 | $400K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4,353 | 4,277 | $394K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 24,774 | 23,840 | $371K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4,383 | 3,606 | $359K |
| 70450 | Computed tomography, head or brain; without contrast material | 6,807 | 6,631 | $325K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 2,913 | 2,876 | $259K |
| 77080 | 7,858 | 7,738 | $238K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 593 | 590 | $209K |
| Q5123 | Injection, rituximab-arrx, biosimilar, (riabni), 10 mg | 89 | 53 | $208K |
| 11721 | 1,874 | 1,873 | $202K | |
| 71045 | Radiologic examination, chest; single view | 35,282 | 29,593 | $193K |
| 99442 | 2,438 | 2,088 | $172K | |
| 0001A | 4,198 | 4,196 | $162K | |
| 0002A | 4,067 | 4,063 | $158K | |
| 92002 | 4,422 | 4,420 | $153K | |
| 90686 | 29,501 | 29,469 | $151K | |
| 20610 | 1,255 | 1,229 | $144K | |
| 0064A | 3,014 | 3,012 | $124K | |
| 90834 | Psychotherapy, 45 minutes with patient | 7,392 | 6,026 | $123K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 4,298 | 4,204 | $117K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6,338 | 6,332 | $112K |
| 71046 | Radiologic examination, chest; 2 views | 13,346 | 11,177 | $108K |
| 99441 | 2,753 | 2,628 | $105K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 2,198 | 1,719 | $98K |
| 99223 | Prolong inpt eval add15 m | 1,052 | 1,033 | $93K |
| 0012A | 2,412 | 2,412 | $90K | |
| 0124A | 2,560 | 2,553 | $89K | |
| 92134 | 3,251 | 1,907 | $85K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 8,874 | 8,803 | $83K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6,363 | 6,353 | $82K |
| 0011A | 2,209 | 2,208 | $80K | |
| 69210 | 1,028 | 949 | $79K | |
| 99443 | 830 | 797 | $76K | |
| 73562 | 4,180 | 3,960 | $74K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3,544 | 3,471 | $73K |
| Q5115 | Injection, rituximab-abbs, biosimilar, (truxima), 10 mg | 20 | 12 | $72K |
| J0178 | Injection, aflibercept, 1 mg | 26 | 26 | $67K |
| 90837 | Psychotherapy, 53 minutes with patient | 2,352 | 1,931 | $67K |
| 96415 | 628 | 499 | $64K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1,372 | 839 | $63K |
| J1756 | Injection, iron sucrose, 1 mg | 2,483 | 1,372 | $63K |
| 92557 | 1,690 | 1,671 | $62K | |
| 0004A | 1,534 | 1,533 | $61K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3,480 | 3,401 | $60K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 1,152 | 1,149 | $60K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 908 | 908 | $58K |
| 0134A | 1,530 | 1,528 | $57K | |
| 92551 | 23,691 | 23,675 | $56K | |
| 0054A | 1,334 | 1,332 | $56K | |
| 97161 | 756 | 754 | $55K | |
| J7999 | Compounded drug, not otherwise classified | 862 | 739 | $50K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 480 | 480 | $49K |
| 72100 | 2,002 | 1,945 | $49K | |
| 73630 | 4,216 | 4,001 | $49K | |
| 90750 | 534 | 534 | $46K | |
| 99232 | Subsequent hospital care, per day, moderate complexity | 2,611 | 992 | $45K |
| 73030 | 2,363 | 2,221 | $45K | |
| 92567 | 2,912 | 2,889 | $42K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2,528 | 2,526 | $42K |
| 0071A | 1,009 | 1,003 | $41K | |
| 92015 | Determination of refractive state | 4,858 | 4,843 | $39K |
| 0072A | 809 | 809 | $32K | |
| 95800 | 153 | 153 | $32K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 63 | 63 | $29K |
| 76641 | 1,055 | 1,049 | $29K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 12,072 | 12,050 | $28K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,762 | 1,439 | $28K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 320 | 320 | $27K |
| J7030 | Infusion, normal saline solution , 1000 cc | 11,557 | 6,807 | $25K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1,931 | 1,904 | $25K |
| 76830 | Ultrasound, transvaginal | 1,671 | 1,645 | $24K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 340 | 228 | $23K |
| 99222 | Initial hospital care, per day, moderate complexity | 313 | 310 | $21K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 263 | 256 | $20K |
| 76813 | 552 | 551 | $19K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 700 | 691 | $18K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 156 | 156 | $18K |
| 73502 | 511 | 405 | $18K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 764 | 614 | $16K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 66 | 66 | $16K |
| 73130 | 1,147 | 1,059 | $16K | |
| 93271 | 47 | 47 | $15K | |
| 90677 | 396 | 396 | $15K | |
| 90656 | 2,615 | 2,614 | $15K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 12,998 | 12,537 | $15K |
| 97535 | Self-care/home management training, each 15 minutes | 573 | 528 | $14K |
| 73610 | 1,272 | 1,239 | $14K | |
| 99233 | Prolong inpt eval add15 m | 428 | 191 | $13K |
| 92227 | 797 | 797 | $13K | |
| 0031A | 334 | 334 | $13K | |
| 99215 | Prolong outpt/office vis | 1,598 | 1,564 | $12K |
| 78451 | 107 | 107 | $12K | |
| 83921 | 375 | 374 | $12K | |
| 92504 | 795 | 720 | $12K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3,011 | 2,768 | $12K |
| 11056 | 110 | 109 | $11K | |
| 97165 | 299 | 298 | $11K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 674 | 674 | $11K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 965 | 963 | $10K |
| 0154A | 252 | 250 | $9K | |
| 99220 | 51 | 50 | $8K | |
| 99397 | 28 | 28 | $8K | |
| 95806 | 61 | 61 | $8K | |
| 76536 | 114 | 113 | $8K | |
| 91200 | 259 | 174 | $8K | |
| 85027 | 4,098 | 4,052 | $8K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 40 | 40 | $8K |
| 90734 | 422 | 422 | $7K | |
| 90678 | 45 | 45 | $7K | |
| J3489 | Injection, zoledronic acid, 1 mg | 134 | 134 | $7K |
| 90651 | 694 | 694 | $7K | |
| 99173 | 14,966 | 14,959 | $7K | |
| G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | 875 | 875 | $7K |
| 90674 | 367 | 367 | $7K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 560 | 556 | $6K |
| 91319 | 288 | 288 | $6K | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 16,341 | 15,850 | $6K |
| 93296 | 105 | 105 | $6K | |
| G0127 | Trimming of dystrophic nails, any number | 101 | 101 | $6K |
| 86360 | 110 | 110 | $6K | |
| S9480 | Intensive outpatient psychiatric services, per diem | 257 | 94 | $5K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 144 | 105 | $5K |
| 72040 | 136 | 135 | $5K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 85 | 85 | $5K |
| 81002 | 2,078 | 2,005 | $5K | |
| 93016 | 102 | 102 | $5K | |
| 86359 | 110 | 110 | $5K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 44 | 44 | $5K |
| 97162 | 37 | 37 | $4K | |
| 76770 | 85 | 85 | $4K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 2,123 | 916 | $4K |
| 90694 | 39 | 39 | $4K | |
| 99177 | 3,975 | 3,970 | $4K | |
| 88141 | 410 | 410 | $4K | |
| 88342 | 125 | 117 | $4K | |
| 77065 | Tomosynthesis, mammo | 118 | 111 | $4K |
| 0051A | 100 | 99 | $4K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | 295 | 127 | $4K |
| 90691 | 142 | 142 | $4K | |
| 90670 | 985 | 984 | $3K | |
| 99239 | Hospital discharge day management, more than 30 minutes | 54 | 54 | $3K |
| 94060 | 42 | 42 | $3K | |
| 98968 | 182 | 161 | $3K | |
| 0074A | 89 | 88 | $3K | |
| 93018 | 101 | 101 | $3K | |
| 0052A | 74 | 74 | $3K | |
| 90715 | 262 | 262 | $3K | |
| 90832 | Psychotherapy, 30 minutes with patient | 94 | 76 | $3K |
| 0081A | 68 | 67 | $3K | |
| 92523 | 123 | 121 | $3K | |
| 99238 | Hospital discharge day management, 30 minutes or less | 57 | 56 | $3K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 200 | 140 | $3K |
| 81329 | 133 | 133 | $2K | |
| 99201 | 402 | 396 | $2K | |
| 97010 | 624 | 459 | $2K | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 1,008 | 486 | $2K |
| 72050 | 53 | 53 | $2K | |
| 93272 | 47 | 47 | $2K | |
| 0082A | 58 | 57 | $2K | |
| 91318 | 185 | 185 | $2K | |
| 90672 | 615 | 615 | $2K | |
| 99234 | 41 | 40 | $2K | |
| 73564 | 73 | 58 | $2K | |
| J8540 | Dexamethasone, oral, 0.25 mg | 352 | 246 | $2K |
| 74018 | 256 | 224 | $2K | |
| 0112A | 51 | 51 | $2K | |
| 0013A | 49 | 49 | $2K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 13 | 13 | $2K |
| 99241 | 39 | 39 | $2K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 12 | 12 | $2K |
| 90648 | 1,409 | 1,407 | $2K | |
| 92587 | 303 | 302 | $2K | |
| 90791 | Psychiatric diagnostic evaluation | 305 | 305 | $2K |
| 99205 | Prolong outpt/office vis | 38 | 38 | $2K |
| 87338 | 974 | 974 | $2K | |
| 93288 | 12 | 12 | $2K | |
| 88307 | 66 | 51 | $2K | |
| 81003 | 1,735 | 1,682 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 53 | 43 | $1K |
| 96361 | Intravenous infusion, hydration; each additional hour | 36 | 31 | $1K |
| 0111A | 37 | 37 | $1K | |
| 11900 | 106 | 97 | $1K | |
| J9035 | Injection, bevacizumab, 10 mg | 12 | 12 | $1K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 124 | 121 | $1K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 46 | 46 | $1K |
| J0640 | Injection, leucovorin calcium, per 50 mg | 20 | 12 | $1K |
| 0003A | 35 | 35 | $1K | |
| 73110 | 245 | 232 | $1K | |
| 73140 | 173 | 166 | $1K | |
| 86580 | 634 | 615 | $1K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 40 | 40 | $1K |
| 90632 | 44 | 44 | $1K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 26 | 26 | $1K |
| 90710 | 26 | 26 | $1K | |
| 96112 | 80 | 80 | $1K | |
| 99417 | Prolong home eval add 15m | 76 | 71 | $1K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 139 | 121 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,801 | 1,795 | $997.79 |
| 90633 | 408 | 408 | $973.30 | |
| 88304 | 120 | 112 | $855.46 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 102 | 101 | $840.07 |
| 92579 | 134 | 134 | $827.79 | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 101 | 61 | $795.00 |
| 81025 | 485 | 479 | $785.14 | |
| 95117 | 88 | 53 | $758.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 766 | 537 | $737.49 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 66 | 66 | $693.00 |
| 90849 | 25 | 12 | $644.00 | |
| 72170 | 65 | 57 | $639.28 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 82 | 64 | $633.64 |
| 90723 | 478 | 478 | $632.53 | |
| 85014 | 269 | 261 | $623.00 | |
| 99051 | 17,384 | 17,294 | $604.72 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 431 | 428 | $592.47 |
| 73523 | 15 | 12 | $585.00 | |
| 90746 | 15 | 15 | $536.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 395 | 394 | $512.67 |
| 99307 | 123 | 98 | $495.10 | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 12 | 12 | $494.57 |
| 92235 | 17 | 16 | $457.24 | |
| J9190 | Injection, fluorouracil, 500 mg | 22 | 12 | $378.18 |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 29 | 12 | $370.66 |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | 99 | 99 | $320.00 |
| 73080 | 56 | 55 | $297.18 | |
| 73590 | 52 | 51 | $284.62 | |
| 90681 | 42 | 41 | $276.07 | |
| 0083A | 44 | 38 | $236.50 | |
| 82962 | 55 | 54 | $230.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 68 | 29 | $222.75 |
| 73560 | 16 | 15 | $207.13 | |
| 90660 | 77 | 77 | $190.00 | |
| 73100 | 12 | 12 | $185.00 | |
| 82274 | 13 | 13 | $183.82 | |
| 99310 | Prolong nursin fac eval 15m | 20 | 18 | $173.14 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 83 | 81 | $169.97 |
| 93971 | 26 | 25 | $158.89 | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 15 | 15 | $150.00 |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 62 | 62 | $145.50 |
| 90696 | 36 | 36 | $137.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 18 | 17 | $128.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 42 | 38 | $86.45 |
| 99188 | 40 | 40 | $80.00 | |
| 90658 | 248 | 248 | $78.91 | |
| 99221 | 13 | 13 | $65.17 | |
| 85046 | 62 | 60 | $60.00 | |
| 90655 | 37 | 37 | $56.00 | |
| 82985 | 13 | 13 | $52.92 | |
| J7050 | Infusion, normal saline solution, 250 cc | 34 | 24 | $31.15 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 32 | 13 | $23.23 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 32 | 28 | $8.80 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 13 | 13 | $0.42 |
| G9920 | Screening performed and negative | 6,206 | 6,205 | $0.06 |
| 1036F | 19,686 | 19,154 | $0.00 | |
| 99024 | 315 | 273 | $0.00 | |
| 3044F | 2,527 | 2,510 | $0.00 | |
| 80051 | 49 | 49 | $0.00 | |
| 90688 | 234 | 232 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 41 | 41 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 68 | 29 | $0.00 |
| 3052F | 147 | 146 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 98 | 98 | $0.00 |
| 83550 | 12 | 12 | $0.00 | |
| 82043 | 15 | 15 | $0.00 | |
| 99318 | 12 | 12 | $0.00 | |
| 82728 | 14 | 14 | $0.00 | |
| 84075 | 12 | 12 | $0.00 | |
| 99354 | 13 | 13 | $0.00 | |
| 3051F | 253 | 250 | $0.00 | |
| 3046F | 187 | 187 | $0.00 | |
| 82565 | 76 | 76 | $0.00 | |
| 87210 | 43 | 42 | $0.00 | |
| 90661 | 105 | 105 | $0.00 | |
| 84460 | 39 | 39 | $0.00 | |
| G9919 | Screening performed and positive and provision of recommendations | 72 | 72 | $0.00 |
| 90756 | 14 | 14 | $0.00 | |
| 90838 | 14 | 12 | $0.00 | |
| 90700 | 14 | 14 | $0.00 | |
| 77072 | 12 | 12 | $0.00 | |
| 80061 | Lipid panel | 29 | 29 | $0.00 |
| 85610 | 14 | 14 | $0.00 | |
| 83540 | 12 | 12 | $0.00 |